---
res:
  bibo_abstract:
  - "Despite the remarkable number of scientific breakthroughs of the last 100 years,
    the treatment of neurodevelopmental\r\ndisorders (e.g., autism spectrum disorder,
    intellectual disability) remains a great challenge. Recent advancements in\r\ngenomics,
    such as whole-exome or whole-genome sequencing, have enabled scientists to identify
    numerous\r\nmutations underlying neurodevelopmental disorders. Given the few hundred
    risk genes that have been discovered,\r\nthe etiological variability and the heterogeneous
    clinical presentation, the need for genotype — along with phenotype-\r\nbased
    diagnosis of individual patients has become a requisite. In this review we look
    at recent advancements in\r\ngenomic analysis and their translation into clinical
    practice.@eng"
  bibo_authorlist:
  - foaf_Person:
      foaf_givenName: Dora-Clara
      foaf_name: Tarlungeanu, Dora-Clara
      foaf_surname: Tarlungeanu
      foaf_workInfoHomepage: http://www.librecat.org/personId=2ABCE612-F248-11E8-B48F-1D18A9856A87
  - foaf_Person:
      foaf_givenName: Gaia
      foaf_name: Novarino, Gaia
      foaf_surname: Novarino
      foaf_workInfoHomepage: http://www.librecat.org/personId=3E57A680-F248-11E8-B48F-1D18A9856A87
    orcid: 0000-0002-7673-7178
  bibo_doi: 10.1038/s12276-018-0129-7
  bibo_issue: '8'
  bibo_volume: 50
  dct_date: 2018^xs_gYear
  dct_identifier:
  - UT:000441266700006
  dct_isPartOf:
  - http://id.crossref.org/issn/2092-6413
  dct_language: eng
  dct_publisher: Springer Nature@
  dct_title: 'Genomics in neurodevelopmental disorders: an avenue to personalized
    medicine@'
  fabio_hasPubmedId: '30089840'
...